Chinese COVID-19 pill coming soon
Share - WeChat

A new COVID-19 medicine made by a Chinese pharmaceutical company in Jiangsu province is expected to go on sale as soon as February, according to the Jiangsu Medical Products Administration.
The pharmaceutical company, Simcere, owns the intellectual property rights for the pill — SIM0417. It was jointly developed with the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences and the Wuhan Institute of Virology.
In mid-December, 1,208 patients were enrolled in the Phase 3 clinical trial of the pill, the administration's notice said.
- China adds 3.08 million new urban jobs in Q1
- Train attendants practice etiquette skills ahead of May Day holiday
- UNGA Resolution 2758 Q&A Series: Question 6
- Improper construction management blamed for Shanghai metro track damage
- Chinese premier chairs meeting on river and lake protection, child welfare
- China expects 27% rise in cross-border travel during May Day holiday